Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor

A technology of B lymphocytes and stimulating factors, which is applied in the fields of peptide/protein components, medical preparations containing active ingredients, genetic engineering, etc., can solve the problems that the heat transfer rate cannot meet the technological requirements and the production cost is high

Inactive Publication Date: 2003-04-09
NEWORGEN
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The defect of the chemical signal-induced regulation mode is high production cost, and the defect of the temperature regulation mode is that the heat transfer rate cannot meet the process requirements

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor
  • Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Cloning of BlyS Coding Region (ORF) and BlyS Extramembrane BlyS-C Sequence

[0064] In order to obtain the ORF sequence of BlyS, the following pair of primers were designed according to the BlyS nucleotide sequence:

[0065] BlyS-F3: 5'-ATCGGAATCCTCACGCCTTACTTCTTGCC-3' (SEQ ID NO: 5)

[0066] BlyS-R3: 5'-ATCGAAGCTTCATGGTGTAAGTAGGTCACAGC-3' (SEQ ID NO: 6)

[0067] The above primers introduced EcoR I and Hind III restriction sites respectively, and the amplified products covered the corresponding DNA sequence from the 10th to the 288th amino acid of BlyS. Using BlyS-F3 and BlyS-R3 as primers, a fragment of about 850 bp was amplified from a human fetal brain library (Clontech). The PCR amplification conditions were: 94°C for 50 sec, 53°C for 1 min, 72°C for 2 min, and the last cycle of extension for 9 min. The PCR product was purified and identified by digestion with Pst I and Dra I respectively, and it was preliminarily confirmed that it was the ORF sequence of BlyS. ...

Embodiment 2

[0073] Construction of expression vector pT7450-BlyS2

[0074] Plasmid pT7-ZZa (Novagen Inc.) was digested with EcoRI and NcoI, and the oligonucleotide fragment 5'-CATGGCATATGG-3' (SEQ ID NO: 9) and 3'-CGTATACCTTAA-5' (SEQ ID NO: 10) was used to ligate the linker formed by T4 DNA ligase, and transform Escherichia coli DH-5α. After digestion and screening, the recombinant plasmid pT7450 was obtained. Plasmid pGEM-BlyS2 was digested with Nde I and Hind III, and the BlyS2 fragment was purified by agarose gel electrophoresis and ligated with the pT7450 vector digested with Nde I and Hind III. Escherichia coli DH-5α was transformed. After enzyme digestion and screening, the recombinant plasmid pT7450-BlyS2 ( figure 1 ) into Escherichia coli JM105. Sequencing proved that the sequence of the recombinant plasmid pT7450-BlyS2 was spliced ​​correctly.

Embodiment 3

[0076] Expression of BlyS-C gene

[0077] The plasmid pT7450-BlyS2 obtained in Example 2 was used to transform Escherichia coli BL21(DE3), and the transformants were inoculated in LB liquid medium containing ampicillin, and cultured with shaking at 37°C until A600=0.5. Add IPTG to a final concentration of 1 mmol / L, and continue shaking culture at 37°C for 4 hours. Bacterial samples were taken before and after IPTG induction and detected by SDS-PAGE electrophoresis. The results showed that about 18KD BlyS-C protein was expressed after induction with IPTG.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to immunoregulation medicine containing pharmacological acceptable carrier and extramembranous section of human B lymphocyte stimulation factor in safe and effective amount. The said extramembranous section of human B lymphocyte stimulation factor has the bioactivity of promoting B cell to mature. The present invention also provides the expression vector, host cell and production process of the extramembranous section of human B lymphocyte stimulation factor. The present invention may be used as new therapeutic protein and the preparation process has high protein product expression amount and no demerit of adding inducer and is suitable for industrial preparation.

Description

technical field [0001] The invention relates to the construction, gene expression and preparation of the expression product of a genetic engineering expression vector of a novel immunomodulatory drug. More specifically, the present invention relates to the extramembrane segment of B lymphocyte stimulating factor and its production method, as well as the expression vector and host bacteria used in the method. Background technique [0002] Lymphocytes are white blood cells with specific immune functions. In the early 1960s, when studying the function of the thymus, it was discovered that there were two types of lymphocytes, namely T cells and B cells. They can enlarge, divide and multiply under the stimulation of antigens, and perform the functions of cellular immunity and humoral immunity respectively. Thus changing the concept that lymphocytes are terminal cells, and confirming the specific immune function of lymphocytes. [0003] Lymphocytes can be divided into at least ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17A61P37/02C12N15/12C12N15/63C12N15/64C12P21/02
Inventor 龚毅杨胜利田瑞阳
Owner NEWORGEN